1. Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures

   • Graciana L. Galiana
   • Angela C. Gauthier
   • Richard H. Mattson

   Review Article Open access 24 July 2017 Pages: 329 - 339

   

2. Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region

   • Renée Dagenais
   • Kyle John Wilby
   • Mary H. H. Ensom

   Systematic Review Open access 26 July 2017 Pages: 341 - 361

   

3. Pharmacokinetic Bioequivalence Studies of an Extended-Release Oxycodone Hydrochloride Tablet in Healthy Japanese Subjects Under Fasting and Fed Conditions Without an Opioid Antagonist

   • Kaoru Toyama
   • Hidetoshi Furuie
   • Hitoshi Ishizuka

   Original Research Article Open access 17 May 2017 Pages: 363 - 370

   

4. Comparison of Generic Drug Reviews for Marketing Authorization between Japan and Canada

   • Ryosuke Kuribayashi
   • Scott Appleton

   Original Research Article Open access 02 June 2017 Pages: 371 - 379

   

5. A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma

   • Takuya Sho
   • Mitsuru Nakanishi
   • Naoya Sakamoto

   Original Research Article Open access 01 June 2017 Pages: 381 - 388

   

6. A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation

   • Satoru Oka
   • Yoko Obata
   • Tomoya Nishino

   Original Research Article Open access 25 May 2017 Pages: 389 - 396

   

7. A Dipeptidyl Peptidase-4 Inhibitor, Teneligliptin, Decreases Plasma Triglyceride-Rich Lipoprotein Remnants in Diabetic Patients with Chronic Kidney Disease Undergoing Hemodialysis

   • Koichiro Homma
   • Joe Yoshizawa
   • Yasuhiko Homma

   Original Research Article Open access 02 June 2017 Pages: 397 - 402

8. Comparative Effect of Calcium Channel Blockers on Glomerular Function in Hypertensive Patients with Diabetes Mellitus

   • Yayoi Nishida
   • Yasuo Takahashi
   • Satoshi Asai

   Original Research Article Open access 03 June 2017 Pages: 403 - 412

   

9. Identification of Polymorphic Forms of Active Pharmaceutical Ingredient in Low-Concentration Dry Powder Formulations by Synchrotron X-Ray Powder Diffraction

   • Kenji Egusa
   • Fumiaki Okazaki
   • Markus Wolkenhauer

   Original Research Article Open access 13 September 2017 Pages: 413 - 418

   

10. Breakthrough Pain Management with Sublingual Fentanyl Tablets in Patients with Cancer: Age Subgroup Analysis of a Multicenter Prospective Study

    • Jordi Guitart
    • María Isabel Vargas
    • Almudena Sanz

    Original Research Article Open access 25 July 2017 Pages: 419 - 425

    

11. A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m² (Dralitem^® vs. Temodal^® Capsules) in Patients with Primary Tumors of the Central Nervous System Under Fasting Conditions

    • Alejandro Muggeri
    • Miguel Vago
    • Santiago Pérez-Lloret

    Original Research Article Open access 29 July 2017 Pages: 427 - 434

    

12. Methodological Study of Vancomycin Dosing in Elderly Patients Using Actual Serum Creatinine Versus Rounded Serum Creatinine

    • Tramaine Young
    • Matt Daniel
    • Jane Green

    Original Research Article Open access 16 August 2017 Pages: 435 - 440

    

13. Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial

    • David J. Webb
    • Blai Coll
    • Dick de Zeeuw

    Original Research Article Open access 22 August 2017 Pages: 441 - 448

    

14. Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine

    • Heather Skor
    • Evan B. Smith
    • Haig Bozigian

    Original Research Article Open access 03 August 2017 Pages: 449 - 459

    

15. Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

    • Paolo Grassi
    • Elena Verzoni
    • Giuseppe Procopio

    Original Research Article Open access 11 August 2017 Pages: 461 - 467

    

16. Pharmacokinetics of Bevacizumab in Three Patients Under the Age of 3 Years with CNS Malignancies

    • Johannes Gojo
    • Robert Sauermann
    • Andreas Peyrl

    short communication Open access 02 June 2017 Pages: 469 - 474

    

17. Lipophilicity Influences Drug Binding to α1-Acid Glycoprotein F1/S Variants But Not to the A Variant

    • Kazuhiko Hanada

    Short Communication Open access 23 June 2017 Pages: 475 - 480

    

18. Effectiveness and Safety of Switching from Innovator Infliximab to Biosimilar CT-P13 in Inflammatory Rheumatic Diseases: A Real-World Case Study

    • Cristina Vergara-Dangond
    • Marina Sáez Belló
    • Juan José Alegre-Sancho

    Short Communication Open access 30 June 2017 Pages: 481 - 485

    

19. Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”

    • Karen Rascati

    Letter to the Editor Open access 20 May 2017 Pages: 487 - 488